A federal judge in Texas on Tuesday rejected Elevance Health’s challenge of the U.S. government's calculation for the health ...

Elevance Health loses $375M bonus revenue as court upholds CMS's Medicare Advantage rating methodology. Read more here.

A federal judge in Texas struck down Elevance Health’s lawsuit that argued the government unfairly lowered its Medicare ...

A federal judge in Texas ruled against Elevance Health's challenge of the U.S. government's Medicare star ratings for some of ...

ELV partners with NACHC to bring Food as Medicine into primary care, targeting nutritional insecurities and chronic disease.

Elevance Health, Inc. ELV has endured a bruising 2025 so far, sliding 20.3% year to date and lagging both its industry peers ...

Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of ...

Elevance Health is integrating its food as medicine program for Medicaid members in community health centers, the insurer ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $395.81, a high estimate of $500.00, and a low estimate of $297.00. A negative shift in sentiment is evident ...

Elevance has a Medicaid presence in 27 states, with OBPC and OBQIP operating in 22. Different structures, better results OBPC and OBQIP have two distinct program designs.

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $570.0 for Elevance Health during the past quarter.

Through the first three quarters, Elevance Health reported $116.7 billion in revenue, an increase of 14.3% from 2021 when the company reported $102.1 billion.